|
시장보고서
상품코드
2050802
심장 수술 기구 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별Cardiac Surgery Instrument Market, By Product Type By Application, By End User, By Geography |
||||||
심장 수술 기구 시장은 2026년에 19억 2,000만 달러로 추정되고, 2033년까지 25억 4,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 4.1%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 19억 2,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 4.10% | 2033년 시장 규모 예측 : | 25억 4,000만 달러 |
심장 수술 분야는 최근 몇 년 동안 괄목할 만한 발전을 이루었고, 이는 환자 결과의 개선과 수술 기술의 향상으로 이어졌습니다. 심장 수술 기구는 이러한 수술에서 매우 중요한 역할을 하고 있으며, 외과 의사가 정밀하고 정확하게 복잡한 수술을 할 수 있도록 돕고 있습니다. 이 기구들은 관상동맥 우회술, 심장 판막 수리 또는 교체, 선천성 심장병 교정 등 다양한 심장 수술을 지원하도록 설계되었습니다.
시장 역학
세계 심장 수술 기구 시장은 몇 가지 요인에 의해 주도되고 있습니다. 첫째, 관상동맥질환, 심부전 등 심혈관 질환의 유병률 증가로 심장 수술에 대한 수요가 증가하고 있습니다. 세계보건기구(WHO)에 따르면, 심혈관 질환은 전 세계적으로 사망원인 1위로 매년 약 1,790만 명의 사망 원인이 되고 있습니다. 이러한 높은 질병 부담으로 인해 효과적인 치료를 위해서는 첨단 수술기구의 사용이 필수적입니다. 세계 심장 수술 기구 시장은 향후 몇 년 동안 꾸준한 성장을 이룰 것으로 예측됩니다. 심혈관 질환의 유병률 증가, 고령 인구 증가, 수술 기구의 기술 발전 등의 요인이 시장 성장을 견인하고 있습니다. 또한 저침습 수술에 대한 수요 증가와 로봇 보조 수술의 도입 확대는 시장 확대를 더욱 촉진하고 있습니다. 또한, 고령 인구 증가도 시장 성장에 기여하고 있습니다. 나이가 들어감에 따라 심혈관 질환 발병 위험이 증가함에 따라 심장 수술에 대한 수요가 증가하고 있습니다. 유엔에 따르면, 2050년까지 전 세계 60세 이상 인구는 21억 명에 달할 것으로 예상되며, 이는 심장 수술 기기의 필요성을 강조하고 있습니다. 또한, 수술기구의 기술적 진보가 시장 성장을 주도하고 있습니다. 로봇보조수술, 최소침습수술과 같은 혁신 기술은 심장 수술에 혁명을 일으켜 환자의 부담을 줄이고 수술 결과를 향상시키고 있습니다. 이러한 발전에는 외과 의사가 복잡한 수술을 정확하고 효율적으로 수행할 수 있도록 도와주는 전용 기기가 필요합니다.
시장 전망은 밝지만, 특정 요인이 시장 성장을 억제할 수 있습니다. 심장 수술 기기의 높은 비용과 이를 조작할 수 있는 숙련된 전문가의 부족이 시장 확대의 걸림돌로 작용하고 있습니다. 또한, 제품 승인에 대한 엄격한 규제 요건과 심장 수술에 따른 합병증 위험도 시장 성장을 저해할 수 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 심장 수술 기기 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 심장 수술 기구 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 심장 수술 기구 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 심장 수술 기구 시장 : 제품 유형별, 2026년-2033년
제5장 심장 수술 기구 시장 : 용도별, 2026년-2033년
제6장 심장 수술 기구 시장 : 최종사용자별, 2026년-2033년
제7장 심장 수술 기구 시장 : 지역별, 2026년-2033년
제8장 경쟁 구도
제9장 섹션
LSH 26.06.12Cardiac Surgery Instrument Market is estimated to be valued at USD 1.92 Bn in 2026 and is expected to reach USD 2.54 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.92 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.10% | 2033 Value Projection: | USD 2.54 Bn |
The field of cardiac surgery has witnessed significant advancements in recent years, leading to improved patient outcomes and enhanced surgical techniques. Cardiac surgery instruments play a crucial role in these procedures, aiding surgeons in performing intricate surgeries with precision and accuracy. These instruments are designed to assist in various cardiac procedures, including coronary artery bypass grafting, heart valve repair or replacement, and congenital heart defect correction.
Market Dynamics
The global cardiac surgery instrument market is driven by several factors. Firstly, the increasing prevalence of cardiovascular diseases, such as coronary artery disease and heart failure, is fueling the demand for cardiac surgeries. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, accounting for approximately 17.9 million deaths each year. This high disease burden necessitates the use of advanced surgical instruments for effective treatment. The global market for cardiac surgery instruments is expected to experience steady growth in the coming years. Factors such as the rising prevalence of cardiovascular diseases, increasing geriatric population, and technological advancements in surgical instruments are driving the market growth. Additionally, the growing demand for minimally invasive procedures and the rising adoption of robotic-assisted surgeries are further propelling the market expansion. Furthermore, the growing geriatric population is contributing to the market growth. With age, the risk of developing cardiovascular diseases increases, leading to a higher demand for cardiac surgeries. According to the United Nations, the global population aged 60 years or above is expected to reach 2.1 billion by 2050, highlighting the need for cardiac surgery instruments. Moreover, technological advancements in surgical instruments are driving market growth. Innovations such as robotic-assisted surgeries and minimally invasive techniques have revolutionized cardiac surgeries, reducing patient trauma and improving surgical outcomes. These advancements require specialized instruments that enable surgeons to perform complex procedures with precision and efficiency.
Despite the positive market outlook, certain factors may restrain market growth. The high cost of cardiac surgery instruments and the lack of skilled professionals to operate these instruments pose challenges to market expansion. Additionally, stringent regulatory requirements for product approval and the risk of complications associated with cardiac surgeries may hinder market growth.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cardiac surgery instrument market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Medtronic, Edwards Lifesciences, Abbott Laboratories, Boston Scientific, LivaNova, Sorin Group (now part of LivaNova), Terumo Corporation, Getinge AB, CryoLife, MicroPort Scientific Corporation, B. Braun, Melsungen AG, Maquet (now part of Getinge AB), W. L. Gore & Associates, Stryker Corporation, and Merit Medical Systems
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cardiac surgery instrument market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac surgery instrument market
Market Segmentation
- By Product Type (Revenue, USD Bn, 2021 - 2033)
- Surgical Instruments
- Monitoring & Diagnostic Instruments
- Cardiopulmonary Bypass Equipment
- Sutures & Staples
- Catheters & Guidewires
- By Application (Revenue, USD Bn, 2021 - 2033)
- Coronary Artery Bypass Grafting (CABG)
- Heart Valve Repair/Replacement
- Arrhythmia Treatment
- Aneurysm Repair
- Congenital Heart Defect Repair
- Transplants
- By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Research Institutes
- By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Cardiac Surgery Instrument Market Companies
- Medtronic
- Murray Surgical
- SternMed GmbH
- CARDIC INSTRUMENTS
- Edwards Lifesciences Corporation.
- Abbott
- Boston Scientific Corporation
- LivaNova, Inc.
- Terumo Corporation
- Getinge
- Artivion, Inc
- MicroPort Scientific Corporation
- Braun SE
- Stryker
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Cardiac Surgery Instrument, By Product Type
- Market Cardiac Surgery Instrument, By Application
- Market Cardiac Surgery Instrument, By End User
- Market Cardiac Surgery Instrument, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing Technological Innovation
- Limited Reimbursement Policies
- Growing popularity of Personalized Medicine
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Cardiac Surgery Instrument Market, By Product Type, 2026 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Surgical Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
- Monitoring & Diagnostic Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
- Cardiopulmonary Bypass Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
- Sutures & Staples
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
- Catheters & Guidewires
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
5. Cardiac Surgery Instrument Market, By Application, 2026 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Coronary Artery Bypass Grafting (CABG)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
- Heart Valve Repair/Replacement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
- Arrhythmia Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
- Aneurysm Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
- Congenital Heart Defect Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
- Transplants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
6. Cardiac Surgery Instrument Market, By End User, 2026 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
7. Cardiac Surgery Instrument Market, By Region, 2026 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2026 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy,
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Murray Surgical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SternMed GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CARDIC INSTRUMENTS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Edwards Lifesciences Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- LivaNova, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Getinge
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Artivion, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MicroPort Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Stryker
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
